Form D · Biotechnology
CMD Bioscience, LLC
Orange, CT · CIK 0001511438
Offering snapshot reported Feb 8, 2011 · SEC filing
- Reported sold
- $150K Offering amount: $225K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 18, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 8, 2011 | Initial | $150,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-155045
Source: Form D, filed Feb 8, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Audie | Director, Executive, Promoter |
| David Audie | Director, Executive, Promoter |
| Charles Boyd | Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
554 Boston Post Road, #318
Orange, CT, 06477
Orange, CT, 06477